Macro-TSH: A Diagnostic Challenge.

Analytic errors Gel filtration chromatography Macro-TSH

Journal

European thyroid journal
ISSN: 2235-0640
Titre abrégé: Eur Thyroid J
Pays: England
ID NLM: 101604579

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 20 02 2020
accepted: 03 06 2020
entrez: 29 3 2021
pubmed: 30 3 2021
medline: 30 3 2021
Statut: ppublish

Résumé

Analytical problems should be considered in case of a discrepancy between the results of biochemical tests and the clinical findings. Macro-hormones often artefactually elevate biochemical tests. A young male was referred with persistently elevated TSH (148 mIU/L) measured by a sandwich electrochemiluminescence immunoassay, ECLIA (Cobas; Roche, Basel, Switzerland). The patient's complaints were unspecific, and he appeared clinically euthyroid. The plasma levels of free T4 and free T3 were within the normal range, thyroid autoantibodies were negative, and thyroid ultrasonography was normal. During a short trial of thyroid hormone substitution, the level of TSH decreased to near-normal levels, but hyperthyroid symptoms emerged. TSH analysed by a different immunoassay (Architect; Abbott, Chicago, IL, USA) yielded similar results. In addition, serial dilutions were performed showing linearity, without detection of heterophilic antibody interference. Gel filtration chromatography confirmed the presence of macro-TSH. The patient harboured macro-TSH, which is a rare condition. The complex binding of TSH to other plasma proteins, most often immunoglobulins, results in elevated plasma TSH. However, the biologically active fraction of TSH is normal, reflected by clinical and biochemical euthyroidism.

Identifiants

pubmed: 33777825
doi: 10.1159/000509184
pii: etj-0010-0093
pmc: PMC7983602
doi:

Types de publication

Case Reports

Langues

eng

Pagination

93-97

Informations de copyright

Copyright © 2020 by European Thyroid Association Published by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

Endocr Rev. 2018 Oct 1;39(5):830-850
pubmed: 29982406
Clin Chem Lab Med. 2009;47(5):604-6
pubmed: 19397486
Clin Endocrinol (Oxf). 2015 Dec;83(6):923-30
pubmed: 25388002
Thyroid. 2018 Oct;28(10):1252-1260
pubmed: 29943675
Clin Chem Lab Med. 2017 Oct 26;55(11):1744-1753
pubmed: 28236625
Thyroid. 2020 Jun;30(6):931-935
pubmed: 32111150
Thyroid. 2017 Feb;27(2):138-146
pubmed: 27785976
J Clin Endocrinol Metab. 2012 Jun;97(6):1823-8
pubmed: 22466337
Eur J Endocrinol. 2016 Jan;174(1):9-15
pubmed: 26438715
Ann Clin Biochem. 2013 Sep;50(Pt 5):416-20
pubmed: 23828944

Auteurs

Camilla Bøgelund Larsen (CB)

Department of Endocrinology, Odense University Hospital, Odense, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Eva Rabing Brix Petersen (ERB)

Department of Clinical Biochemistry and Immunology, Hospital of Southern Jutland, Aabenraa, Denmark.

Martin Overgaard (M)

Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.

Steen Joop Bonnema (SJ)

Department of Endocrinology, Odense University Hospital, Odense, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Classifications MeSH